Page 3 - Sciences Authority News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Asia-Pacific Region: A Hot Spot For Clinical Trials By Mathini Ilancheran, principal analyst, R&D, Beroe Inc. Introduction The Asia-Pacific region has become the hot spot for conducting clinical trials due to the ease of regulatory compliance, the low cost of conducting studies, a growing patient population, and the presence of a few top clinical institutions acting as sites. For example, the regulatory agencies in China are working toward an enhanced clinical trial process by reducing the overall review and approval process. 1 The clinical trial workforce contributes to around 30 to 35% ...

The Asia-Pacific Region: A Hot Spot For Clinical Trials By Mathini Ilancheran, principal analyst, R&D, Beroe Inc. Introduction The Asia-Pacific region has become the hot spot for conducting clinical trials due to the ease of regulatory compliance, the low cost of conducting studies, a growing patient population, and the presence of a few top clinical institutions acting as sites. For example, the regulatory agencies in China are working toward an enhanced clinical trial process by reducing the overall review and approval process. 1 The clinical trial workforce contributes to around 30 to 35% ...

62,000 units of sexual enhancers were stashed in drawers and cupboards.. Read more at straitstimes.com.

Singapore Government Announces Phase 3 Effective 28th December 2020 December 15, 2020 The below statement is as-written by the Ministry of Health As we have made good progress on the key enablers supporting further resumption of activities, the Multi-Ministry Taskforce will start Phase Three of re-opening from 28 December 2020. Even as we cross this milestone, we must continue to remain vigilant in the coming months and avoid an uncontrolled resurgence of cases which could slow or even reverse our progress.  UPDATE ON ENABLERS FOR MOVING INTO PHASE THREE 2.    The Multi-Ministry Taskforce ...